Virginia legislation · 2026 Regular Session
Virginia HB1418: An Act to amend the Code of Virginia by adding in Article 21 of Chapter 2 of Title 32.1 a section numbered 32.1-73.21:1, relating to Sickle Cell Trait Awareness and Education Program established.
Status: Chaptered, April 13, 2026
Sickle Cell Trait Awareness and Education Program established. Directs the Department of Health to establish the Sickle Cell Trait Awareness and Education Program to raise public awareness of and provide education on sickle cell trait.
What the bill says
An Act to amend the Code of Virginia by adding in Article 21 of Chapter 2 of Title 32.1 a section numbered 32.1-73.21:1, relating to Sickle Cell Trait Awareness and Education Program established. [H 1418] Approved April 13, 2026 1. That the Code of Virginia is amended by adding in Article 21 of Chapter 2 of Title 32.1 a section numbered 32.1-73.21:1, as follows: Article 21. [DELETED: Adult] [DELETED: Wellness] [DELETED: Screening.] Sickle Cell. § 32.1-73.21:1. Sickle Cell Trait Awareness and Education Program. The Department shall establish and administer the Sickle Cell Trait Awareness and Ed.
From the enrolled text, April 13, 2026:
An Act to amend the Code of Virginia by adding in Article 21 of Chapter 2 of Title 32.1 a section numbered 32.1-73.21:1, relating to Sickle Cell Trait Awareness and Education Program established. [H 1418] Approved April 13, 2026 1. That the Code of Virginia is amended by adding in Article 21 of Chapter 2 of Title 32.1 a section numbered 32.1-73.21:1, as follows: Article 21. [DELETED: Adult] [DELETED: Wellness] [DELETED: Screening.] Sickle Cell. § 32.1-73.21:1. Sickle Cell Trait Awareness and Education Program. The Department shall establish and administer the Sickle Cell Trait Awareness and Education Program (the Program) to (i) conduct public awareness campaigns; (ii) provide educational resources; (iii) provide training to professionals, including health care providers, genetic counselors, school nurses, and educators; (iv) conduct community outreach; and (v) coordinate with existing infrastructure for screening and treatment of sickle cell trait and sickle cell disease. The Program shall provide information on screening services conducted pursuant to §§ 32.1-68 and 32.1-73.21 and newborn screening conducted pursuant to Article 7 (§ 32.1-65 et seq.).